...
首页> 外文期刊>African Journal of Pharmacy and Pharmacology >Effects of Angelica polysaccharide on erythrocyte immunity and marrow hematopoiesis in chickens
【24h】

Effects of Angelica polysaccharide on erythrocyte immunity and marrow hematopoiesis in chickens

机译:当归多糖对鸡红细胞免疫和骨髓造血的影响

获取原文
           

摘要

To investigate the effects of?Angelica?polysaccharide on erythrocyte immunity and marrow hematopoiesis in chickens,?Angelica?polysaccharide was used for the study of immunity and hematinic mechanism in order to provide basis for clinical reference. In this experiment, three gradient dosages (50, 100, 150 mg/kg body weight) of?Angelica?polysaccharide were drenched to the control group and the anemia groups, respectively. The anemia chickling model was made by abdominal injection of cyclophosphamide (CY) for 6 days (80 mg/kg·day).Red blood cell-C3b receptor (RBC-CR1) and red blood cell-immune complex (RBC-IC) rosette rates were measured and analyzed. Ectogenetic semi-solid culture medium of bone marrow hemopoietic progenitor cells was used to observe?Angelica?polysaccharide and separated serum fromAngelica?polysaccharide?treatment?on the proliferation of colony-forming unit-erythrocyte (CFU-E), burst-forming unit-erythrocyte (BFU-E) and colony-forming unit-granulocyte macrophage (CFU-GM). The results showed that?Angelica?polysaccharide can significantly increase RBC-CR1 rosette rate in the healthy chicken groups (p0.05). At the same time,?Angelica?polysaccharide can restore the RBC- CR1 rosette rate and the RBC-IC rosette rate caused by cyclophosphamide to the normal level. Serum containing?Angelica?polysaccharide can significantly facilitate the proliferation on CFU-E (p<0.01), BFU-E (p<0.01) and CFU-GM (p<0.01), but?Angelica?polysaccharide had no more direct proliferation on CFU-E, BFU-E and CFU-GM. This indicated that?Angelica?polysaccharide had the proliferation on hemopoietic progenitor cells of marrow by the change of hemopoietic factor.
机译:为了研究“当归”多糖对鸡的红细胞免疫和骨髓造血作用的影响,“当归”多糖被用于研究免疫力和血凝机制,以提供临床参考依据。在该实验中,分别将三个梯度剂量(50、100、150 mg / kg体重)的“当归”多糖浸入对照组和贫血组。腹腔注射环磷酰胺(CY)6天(80 mg / kg·天)建立贫血雏鸡模型。红细胞C3b受体(RBC-CR1)和红细胞免疫复合物(RBC-IC)花环率进行了分析。用骨髓造血祖细胞的致癌半固态培养基观察当归多糖和从当归多糖处理中分离的血清对集落形成单位红细胞(CFU-E),爆发形成单位的增殖。红细胞(BFU-E)和集落形成单位-粒细胞巨噬细胞(CFU-GM)。结果表明,当归多糖能显着提高健康鸡群的RBC-CR1玫瑰花结率(p0.05)。同时,当归多糖能使环磷酰胺引起的RBC-CR1玫瑰花率和RBC-IC玫瑰花率恢复到正常水平。含“当归”多糖的血清可显着促进CFU-E(p <0.01),BFU-E(p <0.01)和CFU-GM(p <0.01)的增殖,而“当归”多糖在CFU-E(p <0.01),CFU-GM(p <0.01)上却没有更直接的增殖。 CFU-E,BFU-E和CFU-GM。这表明当归多糖通过造血因子的改变在骨髓造血祖细胞中具有增殖作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号